BioStock: Enzymatica boosts Q4 revenue but sees room for stronger partner sales

The cold season is in full swing, which is also reflected in Enzymatica’s fourth-quarter report, showing increased sales compared to the same period in 2023. However, full-year revenue declined compared to the previous year, primarily due to the absence of sales through partners. BioStock reached out to the company’s CEO, Claus Egstrand, to learn more.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/02/enzymatica-boosts-q4-revenue-but-sees-room-for-stronger-partner-sales/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se